Maharashtra FDA permanently cancels Pune-based pharma firm’s license over six contaminated medicines, GMP lapses
The Maharashtra Food and Drug Administration (FDA) on Thursday (August 6, 2026) permanently cancelled the Ayurvedic medicine manufacturing license of Pune-based InduCare Pharma Pvt. Ltd. after six medicines failed quality tests, with some found contaminated with fungi, insects and larvae, and widespread Good Manufacturing Practice (GMP) violations. This action was taken after the manufacturing facility […]
Continue Reading